Satoshi Fukushima Selected Research

Docetaxel (Taxotere)

1/2020	Case of metastatic extramammary Paget's disease treated with trastuzumab-biosimilar monotherapy after S-1 and docetaxel combination chemotherapy.
5/2017	Achieved good response of S-1 and docetaxel combination chemotherapy in two patients with metastatic extramammary Paget's disease.
2/2015	Combination chemotherapy with S-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi Fukushima Research Topics

Disease

62	Melanoma (Melanoma, Malignant) 03/2024 - 11/2005
54	Neoplasms (Cancer) 04/2024 - 01/2008
21	Systemic Scleroderma (Systemic Sclerosis) 06/2022 - 02/2012
16	Fibrosis (Cirrhosis) 01/2024 - 02/2012
16	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2023 - 03/2011
10	Autoimmune Diseases (Autoimmune Disease) 05/2020 - 01/2010
9	Extramammary Paget Disease (Paget Disease, Extramammary) 09/2023 - 02/2015
8	Hemangiosarcoma (Angiosarcoma) 10/2021 - 02/2015
8	Neoplasm Metastasis (Metastasis) 07/2021 - 10/2013
8	Dermatomyositis (Dermatopolymyositis) 10/2015 - 09/2011
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2024 - 02/2014
6	Onychomycosis (Tinea Unguium) 12/2023 - 10/2018
5	Inflammation (Inflammations) 09/2021 - 02/2012
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2017 - 10/2012
4	Carcinogenesis 11/2023 - 02/2014
4	Disease Progression 01/2023 - 01/2016
4	Infections 09/2021 - 05/2011
4	Collagen Diseases (Collagen Disease) 05/2020 - 09/2011
4	Myasthenia Gravis 11/2018 - 07/2016
4	Myositis (Idiopathic Inflammatory Myopathies) 11/2018 - 10/2012
3	Skin Diseases (Skin Disease) 04/2024 - 08/2014
3	Hemangioma (Angioma) 03/2023 - 12/2010
3	Erythema 03/2023 - 08/2017
3	Pemphigus (Pemphigus Vulgaris) 01/2021 - 04/2013
3	Ulcer 08/2017 - 09/2013
3	Cicatrix (Scar) 08/2017 - 09/2013
3	Rheumatic Diseases (Rheumatism) 10/2015 - 07/2012
3	Localized Scleroderma (Morphea) 09/2013 - 01/2013
2	Alopecia Areata 04/2024 - 04/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 03/2020
2	Uveitis 11/2023 - 03/2023
2	Microsatellite Instability 05/2022 - 02/2022
2	Skin Neoplasms (Skin Cancer) 01/2022 - 07/2017
2	Psoriatic Arthritis 09/2020 - 04/2016
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2020 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2020 - 04/2015

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2005
20	MicroRNAs (MicroRNA)IBA 09/2023 - 12/2010
18	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2005
18	NivolumabIBA 01/2024 - 01/2016
17	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2016
14	CytokinesIBA 04/2024 - 03/2011
14	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 07/2012
14	CollagenIBA 06/2022 - 02/2012
12	AntigensIBA 12/2023 - 04/2009
11	Messenger RNA (mRNA)IBA 09/2023 - 12/2010
9	IpilimumabIBA 03/2023 - 09/2017
9	AntibodiesIBA 08/2022 - 01/2008
8	Cell-Free Nucleic AcidsIBA 04/2024 - 09/2020
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 01/2015
7	Bleomycin (Blenoxane)FDA LinkGeneric 06/2022 - 04/2013
7	Peptides (Polypeptides)IBA 02/2021 - 11/2008
6	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2023 - 04/2014
5	LigandsIBA 10/2023 - 01/2016
5	Tumor Biomarkers (Tumor Markers)IBA 01/2016 - 11/2005
4	Angiopoietin-Like Protein 2IBA 03/2024 - 02/2012
4	Collagen Type I (Type I Collagen)IBA 01/2024 - 04/2012
4	Terbinafine (Lamisil)FDA LinkGeneric 09/2021 - 04/2014
4	EnzymesIBA 07/2017 - 09/2011
3	pembrolizumabIBA 03/2024 - 01/2019
3	dabrafenibIBA 01/2024 - 06/2018
3	trametinibIBA 01/2024 - 06/2018
3	InterferonsIBA 01/2024 - 05/2018
3	IntegrinsIBA 12/2023 - 01/2013
3	efinaconazoleIBA 10/2023 - 10/2018
3	Interleukin-23 (Interleukin 23)IBA 01/2023 - 01/2017
3	Small Interfering RNA (siRNA)IBA 06/2022 - 01/2015
3	VaccinesIBA 02/2022 - 04/2009
3	Circulating MicroRNAIBA 01/2022 - 03/2011
3	Interleukin-17 (Interleukin 17)IBA 02/2021 - 01/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2020 - 01/2014
3	Docetaxel (Taxotere)FDA Link 01/2020 - 02/2015
3	Silver Sulfadiazine (SSD)FDA LinkGeneric 10/2015 - 09/2013
3	ImmunosorbentsIBA 09/2013 - 09/2011
2	Ophthalmic Solutions (Eye Drops)IBA 02/2024 - 03/2023
2	ChemokinesIBA 10/2023 - 01/2018
2	Phosphotransferases (Kinase)IBA 10/2023 - 03/2016
2	Interleukin-8 (Interleukin 8)IBA 10/2023 - 09/2018
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2023 - 06/2008
2	Programmed Cell Death 1 ReceptorIBA 01/2023 - 03/2021
2	Janus Kinase 2IBA 01/2023 - 07/2021
2	alpha2 Subunit Collagen Type IIBA 06/2022 - 09/2015
2	PromegaIBA 05/2022 - 02/2022
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2021 - 01/2016
2	B7-H1 AntigenIBA 03/2021 - 01/2018
2	EpitopesIBA 02/2021 - 11/2008
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2016
2	cadherin 5IBA 10/2020 - 08/2014
2	AutoantibodiesIBA 08/2020 - 05/2020
2	Bexarotene (LGD1069)FDA Link 06/2020 - 01/2019

Therapy/Procedure

48	Therapeutics 03/2024 - 01/2008
22	Immunotherapy 04/2024 - 04/2009
4	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 03/2016
3	Drug Therapy (Chemotherapy) 01/2023 - 02/2015
3	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 02/2015
3	Lymph Node Excision (Lymph Node Dissection) 08/2016 - 01/2011
3	Transplantation 11/2011 - 01/2010
2	Aftercare (After-Treatment) 03/2023 - 02/2021
2	Injections 08/2022 - 02/2021
2	Radiotherapy 11/2021 - 05/2020